Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 28;31(28):108321.
doi: 10.3748/wjg.v31.i28.108321.

Construction of a community-based primary screening and hospital-based confirmatory screening pathway in pediatric nonalcoholic fatty liver disease

Ming-Jie Yao  1 , Yun-Fei Xing  2 , Shu-Hong Liu  3 , Ya-Fei Peng  4 , Shu-Han Yang  2 , Juan-Juan Chen  5 , Jing-Min Zhao  6 , Hui Wang  7
Affiliations

Construction of a community-based primary screening and hospital-based confirmatory screening pathway in pediatric nonalcoholic fatty liver disease

Ming-Jie Yao et al. World J Gastroenterol. .

Abstract

Background: Fibrosis is a critical event in the progression of pediatric nonalcoholic fatty liver disease (NAFLD).

Aim: To develop less invasive models based on machine learning (ML) to predict significant fibrosis in Chinese NAFLD children.

Methods: In this cross-sectional study, 222 and 101 NAFLD children with available liver biopsy data were included in the development of screening models for tertiary hospitals and community health centers, respectively. Predictive factors were selected using least absolute shrinkage and selection operator regression and stepwise logistic regression analyses. Logistic regression (LR) and other ML models were applied to construct the prediction models.

Results: Simplified indicators of the ATS and BIU indices were constructed for tertiary hospitals and community health centers, respectively. When models based on the ATS and BIU parameter combinations were constructed, the random forest (RF) model demonstrated higher screening accuracy compared to the LR model (0.80 and 0.79 for the RF model and 0.72 and 0.77 for the LR model, respectively). Using cutoff values of 90% for sensitivity and 90% for specificity, the RF models could effectively identify and exclude NAFLD children with significant fibrosis in the internal validation set (with positive predictive values and negative prediction values exceeding 0.80), which could prevent liver biopsy in 60% and 71.4% of NAFLD children, respectively.

Conclusion: This study developed new models for predicting significant fibrosis in NAFLD children in tertiary hospitals and community health centers, which can serve as preliminary screening tools to detect the risk population in a timely manner.

Keywords: Children; Less invasive test; Machine learning; Nonalcoholic fatty liver disease; Significant fibrosis.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Figures

Figure 1
Figure 1
Flowchart for the selection of study subjects. The development process of the model is shown above. Regarding the left part of the figure, based on the data of 222 children with nonalcoholic fatty liver disease (NAFLD), a tertiary hospital screening model was established via variable screening and combination; regarding the right part of the figure, screening models for community health centers were developed based on the data of 101 NAFLD children using the same method. NAFLD: Nonalcoholic fatty liver disease; HDL: High-density lipoprotein cholesterol; BMI: Body mass index; UA: Uric acid; ML: Machine learning.
Figure 2
Figure 2
Graphical abstract. ATS was a logistic regression model developed in this study that included six parameters: Alkaline phosphatase, total bile acid, aspartate aminotransferase, cholinesterase, high-density lipoprotein cholesterol, and fibrinogen. ML: Machine learning.
See this image and copyright information in PMC

References

    1. Li J, Ha A, Rui F, Zou B, Yang H, Xue Q, Hu X, Xu Y, Henry L, Barakat M, Stave CD, Shi J, Wu C, Cheung R, Nguyen MH. Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021. Aliment Pharmacol Ther. 2022;56:396–406. - PubMed
    1. Xiao Y, Pan YF, Dai Y, Sun YJ, Zhou Y, Yu YF. [Meta analysis of the prevalence and risk factors of non-alcoholic fatty liver disease in overweight and obese children and adolescents in China] Zhongguo Dang Dai Er Ke Za Zhi. 2025;27:410–419. - PMC - PubMed
    1. Wang Y, Yang ZR, Chen RH. [Meta-analysis of the prevalence of non-alcoholic fatty liver disease in Chinese children] Zhongguo Ertong Baojian Zazhi. 2022;30:764–769.
    1. Hagström H, Nasr P, Ekstedt M, Hammar U, Stål P, Hultcrantz R, Kechagias S. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol. 2017;67:1265–1273. - PubMed
    1. Lefere S, Dupont E, De Guchtenaere A, Van Biervliet S, Vande Velde S, Verhelst X, Devisscher L, Van Vlierberghe H, Geerts A, De Bruyne R. Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2022;20:2317–2326.e4. - PubMed

MeSH terms